Stay updated on Tuspetinib in AML: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Tuspetinib in AML: Safety & Efficacy Clinical Trial page.

Latest updates to the Tuspetinib in AML: Safety & Efficacy Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2; removed the government funding lapse notice and Revision: v3.4.1.SummaryDifference0.2%

- Check21 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and the NIH Clinical Center's operating status, with guidance to visit cc.nih.gov and opm.gov for updates. Updated the page's release notes from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check28 days agoChange DetectedThe page now includes a 'Show glossary' option and updated study record date labels such as 'Last Update Submitted that Met QC Criteria' and 'Last Update Posted', with older labels removed or updated. Footer metadata has been updated to include 'No FEAR Act Data' and 'Revision: v3.4.0', while 'No FEAR Act data' and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no substantive changes to study details, eligibility criteria, or locations are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedThe study Locations sections were updated: new locations were added and existing ones removed, altering the list of recruiting sites. A revision tag (Revision: v3.3.3) was added to the page.SummaryDifference1%

- Check85 days agoChange DetectedRevision: v3.3.2 appears on the page header, replacing the previous Revision: v3.3.1. This is a minor update with no visible changes to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Tuspetinib in AML: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tuspetinib in AML: Safety & Efficacy Clinical Trial page.